Alpha RegistryClaim a profile
Published mark

Bicara Therapeutics Inc.

NASDAQ: BCAX. Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e
SEC CIK
0002023658
Record version
vpublic-1:ro-d751713988987e9331980363e24189ce, published Oct 24, 2026
Newest evidence
Apr 27, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Not published
Chair
Not published
Independent
Not published9 directors published
Published claims
192 distinct sources
Evidence records
30 pinned
Source conflicts
0None open

Built from 2 distinct sources and 3 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

DIRECTOR APPOINTED

Christopher Bowden seat on Bicara Therapeutics Inc., effective 2024-01-01.

EffectiveEffective Jan 1, 2024E2

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Board of directors

Evidence

9 directors published. Independence determinations are not published for every director.

DirectorStatusSinceCommitteesClaim
Carolyn NgIndependence not published2023AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INCSource reportedE2
Christopher BowdenIndependence not published2024None publishedSource reportedE2
Claire MazumdarIndependence not published2020None publishedSource reportedE2
Jake SimsonIndependence not published2023None publishedSource reportedE2
Kate HavilandIndependence not published2023None publishedSource reportedE2
Kiran Mazumdar-ShawIndependence not published2018None publishedSource reportedE2
Michael PowellIndependence not published2024AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INCSource reportedE2
Ryan CohlheppIndependence not published2024None publishedSource reportedE2
Scott RobertsonIndependence not published2023AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC, chairSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INCScott RobertsonScott Robertson, Carolyn Ng, Michael PowellNot described in the published record
Committee RecordAUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC: Chair Scott Robertson; Members Scott Robertson (Chair); Carolyn Ng; Michael Powell
Source reportedE3
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_record:16
Committee AppointmentScott Robertson: chair, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC
Source reportedE3
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:17
Committee AppointmentCarolyn Ng: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC
Source reportedE3
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:18
Committee AppointmentMichael Powell: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC
Source reportedE3
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:committee_appointment:19

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingBCAX (NASDAQ)
Source reportedE1
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:security_listing:20
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 24, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameBicara Therapeutics Inc.
Source reportedE1
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:entity_status:3
Published FactHealthcare
Source reportedE1
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:5
Published FactBiotechnology
Source reportedE1
company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e:published_fact:6

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • LeadershipNot reviewed. Executive leadership carries operating authority.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
3 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 24, 2026. Cited by 6 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    DEF 14A bcax-20260427.htm
    sec proxy. Published Apr 27, 2026. Retrieved Sep 2, 2026. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC
    governance_people_committees. sec proxy. Cited by 4 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:ro-d751713988987e9331980363e24189ce

vpublic-1:ro-d751713988987e9331980363e24189ce published Oct 24, 2026
  • Christopher Bowden seat on Bicara Therapeutics Inc., effective 2024-01-01.
  • Michael Powell seat on Bicara Therapeutics Inc., effective 2024-01-01.
  • Ryan Cohlhepp seat on Bicara Therapeutics Inc., effective 2024-01-01.
  • Carolyn Ng seat on Bicara Therapeutics Inc., effective 2023-01-01.
  • Jake Simson seat on Bicara Therapeutics Inc., effective 2023-01-01.
  • Kate Haviland seat on Bicara Therapeutics Inc., effective 2023-01-01.
  • Scott Robertson seat on Bicara Therapeutics Inc., effective 2023-01-01.
  • Claire Mazumdar seat on Bicara Therapeutics Inc., effective 2020-01-01.
  • Kiran Mazumdar-Shaw seat on Bicara Therapeutics Inc., effective 2018-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e, version public-1:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/bicara-therapeutics-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership0
  4. Board9
  5. Committees1
  6. Control and voting0
  7. Authority to act3
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims5
  15. Coverage gaps18
  16. Linked people9
  17. Subject and corrections6
  18. Evidence3
  19. Version historyvpublic-1:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58e
  • Cite this recordBicara Therapeutics Inc.
  • Copy canonical URLregistry.alpha.ac/companies/bicara-therapeutics-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Bicara Therapeutics Inc.Company
  • Carolyn NgPerson
  • Christopher BowdenPerson
  • Claire MazumdarPerson
  • Jake SimsonPerson
  • Kate HavilandPerson
  • Kiran Mazumdar-ShawPerson
  • Michael PowellPerson
  • Ryan CohlheppPerson
  • Scott RobertsonPerson
  • Sections
    OverviewBicara Therapeutics Inc.
  • MonitoringBicara Therapeutics Inc.
  • LeadershipBicara Therapeutics Inc.
  • BoardBicara Therapeutics Inc.
  • CommitteesBicara Therapeutics Inc.
  • Control and votingBicara Therapeutics Inc.
  • Authority to actBicara Therapeutics Inc.
  • FinancialsBicara Therapeutics Inc.
  • GovernanceBicara Therapeutics Inc.
  • RiskBicara Therapeutics Inc.
  • AI oversightBicara Therapeutics Inc.
  • LegalBicara Therapeutics Inc.
  • CompensationBicara Therapeutics Inc.
  • Other published claimsBicara Therapeutics Inc.
  • Coverage gapsBicara Therapeutics Inc.
  • Linked peopleBicara Therapeutics Inc.
  • Subject and correctionsBicara Therapeutics Inc.
  • EvidenceBicara Therapeutics Inc.
  • Version historyBicara Therapeutics Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.